Opinion

Breaking Convention Is No Conference for Suits

Journey to the druidic land of Exeter for the sixth psychedelic gathering harmonizing psychedelic science and culture.

How TransTech Can Give Agency to Humanity

In this interview, technologist Raad Seraj discusses how intent informs technology’s effects, why network and community is the most powerful aspect of tech, and the point of spiritual development. 

Psychedelic Researchers in Europe Proceed with Caution

Compared to other psychedelic conferences, ECNP was a dose of European realism – from the anticipated effect sizes of psychedelic trials to the cut and tailoring of suits and outfits.

Researchers Come Closer to Understanding How Psychedelics Effect Serotonin Receptors

Groundbreaking experiments shed new light on how psychedelics interact with cells to promote neuroplasticity.

Are Psychedelics a New Paradigm or Business as Usual?

Many starry-eyed entrepreneurs view the psychedelic industry as radically new; unfortunately, it may end up collapsing in on itself like cryptocurrency.

A Tale of Two Strategies: Does COMPASS Have the Right One?

The company views patents and monopolies as necessary ingredients for success, while others suggest the strategy hinders industry growth and innovation. 

Where Did 2022 Take the Psychedelic Medicine Field?

The past year saw plummeting valuations for psychedelic companies, a late comeback for stock values, emerging methodical challenges in clinical trials, and some organizations’ strategic – but contested – move away from psychedelia’s “cultural baggage.”

Exploring the Challenges of Psychedelic Integration

A new research project aims to destigmatize long lasting negative psychedelic experiences and investigate support methods.

Colorado’s Decriminalization of Ibogaine Comes With Unique Risks

While there is reason to celebrate any drug policy reform victory, Coloradans need to be aware of the unique risks particular to ibogaine.

How Should Young People Learn About Drugs?

Harm reduction may be the answer, but D.A.R.E. programs are still active in 75 % of U.S. school districts and in more than 43 countries.